If you have any question, please feel free to email us. We will touch with you as soon as possible.
MabThera is indicated for the treatment of relapsed or chemotherapy-resistant intolerant B-cell non-Hodgkin lymphoma. For R&D purposes only.
* Please be kindly noted products are supplied for RLD supplies/ Reference listed drugs/ Comparator Drug Clinical trials. We do not sell to patients.
Generic name | Rituximab Injection |
Trade name | MabThera |
Specification |
100mg/10ml 500mg/50ml |
Main ingredients |
Active ingredients:Rituximab. In addition to the active ingredient, this medicine contains the following inactive ingredients: sodium citrate, polysorbate 80, sodium chloride and water for injection |
Appearance | This product is colorless or light yellow clear liquid, no foreign matter, flocculent and precipitation. |
MA Holder | Roche Pharma(Schweiz)AG |
Manufacturer | Roche Diagnostics GmbH |
Indications:
MabThera is indicated for the treatment of relapsed or chemotherapy-resistant intolerant B-cell non-Hodgkin lymphoma.
Ease recurrence or resistant follicular symptoms of central type of lymphoma.
Alleviate the CD20 positive II - IV follicular symptoms of non-hodgkin's lymphoma.
Ease the CD20 positive symptoms of diffuse large B cell non-hodgkin's lymphoma.
For more details,pls contact Janney:
Email: tosun-global@upharm.cn
Wechat/Whatsapp:(+86)18922120575
Hot Tags: MabThera 100mg/10ml 500mg/50ml Rituximab Injection Reference Listed Drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, AdapaleneGel, Adefovir Dipivoxil Tablets, Esomeprazole Magnesium Enteric Coated Capsules, Agomelatine Tablets, Reference Listed Drugs, Alfacalcidol Soft Capsules
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China